Literature DB >> 24456932

Approach to the diagnosis of congenital myopathies.

Kathryn N North1, Ching H Wang2, Nigel Clarke3, Heinz Jungbluth4, Mariz Vainzof5, James J Dowling6, Kimberly Amburgey6, Susana Quijano-Roy7, Alan H Beggs8, Caroline Sewry9, Nigel G Laing10, Carsten G Bönnemann11.   

Abstract

Over the past decade there have been major advances in defining the genetic basis of the majority of congenital myopathy subtypes. However the relationship between each congenital myopathy, defined on histological grounds, and the genetic cause is complex. Many of the congenital myopathies are due to mutations in more than one gene, and mutations in the same gene can cause different muscle pathologies. The International Standard of Care Committee for Congenital Myopathies performed a literature review and consulted a group of experts in the field to develop a summary of (1) the key features common to all forms of congenital myopathy and (2) the specific features that help to discriminate between the different genetic subtypes. The consensus statement was refined by two rounds of on-line survey, and a three-day workshop. This consensus statement provides guidelines to the physician assessing the infant or child with hypotonia and weakness. We summarise the clinical features that are most suggestive of a congenital myopathy, the major differential diagnoses and the features on clinical examination, investigations, muscle pathology and muscle imaging that are suggestive of a specific genetic diagnosis to assist in prioritisation of genetic testing of known genes. As next generation sequencing becomes increasingly used as a diagnostic tool in clinical practise, these guidelines will assist in determining which sequence variations are likely to be pathogenic.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital myopathy; Diagnosis; Guidelines

Mesh:

Year:  2013        PMID: 24456932      PMCID: PMC5257342          DOI: 10.1016/j.nmd.2013.11.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  90 in total

1.  Missense mutations of ACTA1 cause dominant congenital myopathy with cores.

Authors:  A M Kaindl; F Rüschendorf; S Krause; H-H Goebel; K Koehler; C Becker; D Pongratz; J Müller-Höcker; P Nürnberg; G Stoltenburg-Didinger; H Lochmüller; A Huebner
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

2.  Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation.

Authors:  Adele D'Amico; Claudio Graziano; Giuseppe Pacileo; Stefania Petrini; Kristen J Nowak; Renata Boldrini; Adam Jacques; Juan-Juan Feng; Berardino Porfirio; Caroline A Sewry; Filippo M Santorelli; Giuseppe Limongelli; Enrico Bertini; Nigel Laing; Steven B Marston
Journal:  Neuromuscul Disord       Date:  2006-09-01       Impact factor: 4.296

3.  TPM2 mutation.

Authors:  Almuth Brandis; Eleonora Aronica; Hans H Goebel
Journal:  Neuromuscul Disord       Date:  2008-09-11       Impact factor: 4.296

4.  Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation.

Authors:  K G Claeys; T Maisonobe; J Böhm; J Laporte; M Hezode; N B Romero; G Brochier; M Bitoun; R Y Carlier; T Stojkovic
Journal:  Neurology       Date:  2010-02-09       Impact factor: 9.910

5.  Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.

Authors:  Rachel D Susman; Susana Quijano-Roy; Nan Yang; Richard Webster; Nigel F Clarke; Jim Dowling; Marina Kennerson; Garth Nicholson; Valerie Biancalana; Biljana Ilkovski; Kevin M Flanigan; Susan Arbuckle; Chandra Malladi; Phillip Robinson; Steven Vucic; Michèle Mayer; Norma B Romero; Jon Andoni Urtizberea; Federico García-Bragado; Pascale Guicheney; Marc Bitoun; Robert-Yves Carlier; Kathryn N North
Journal:  Neuromuscul Disord       Date:  2010-03-12       Impact factor: 4.296

6.  Mutations in dynamin 2 cause dominant centronuclear myopathy.

Authors:  Marc Bitoun; Svetlana Maugenre; Pierre-Yves Jeannet; Emmanuelle Lacène; Xavier Ferrer; Pascal Laforêt; Jean-Jacques Martin; Jocelyn Laporte; Hanns Lochmüller; Alan H Beggs; Michel Fardeau; Bruno Eymard; Norma B Romero; Pascale Guicheney
Journal:  Nat Genet       Date:  2005-10-16       Impact factor: 38.330

7.  Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.

Authors:  Michael W Lawlor; Elizabeth T Dechene; Emily Roumm; Amelia S Geggel; Behzad Moghadaszadeh; Alan H Beggs
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

8.  Nebulin (NEB) mutations in a childhood onset distal myopathy with rods and cores uncovered by next generation sequencing.

Authors:  Mariacristina Scoto; Thomas Cullup; Sebahattin Cirak; Shu Yau; Adnan Y Manzur; Lucy Feng; Thomas S Jacques; Glenn Anderson; Stephen Abbs; Caroline Sewry; Heinz Jungbluth; Francesco Muntoni
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

9.  Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.

Authors:  Heinz Jungbluth; Tom Cullup; Suzanne Lillis; Haiyan Zhou; Stephen Abbs; Caroline Sewry; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2009-11-22       Impact factor: 4.296

10.  Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.

Authors:  Marc Bitoun; Jorge A Bevilacqua; Bernard Prudhon; Svetlana Maugenre; Ana Lia Taratuto; Soledad Monges; Fabiana Lubieniecki; Claude Cances; Emmanuelle Uro-Coste; Michèle Mayer; Michel Fardeau; Norma B Romero; Pascale Guicheney
Journal:  Ann Neurol       Date:  2007-12       Impact factor: 10.422

View more
  74 in total

1.  Dihydropyridine Receptor Congenital Myopathy In A Consangineous Turkish Family.

Authors:  Uluç Yiş; Semra Hiz; Sezgin Güneş; Gülden Diniz; Figen Baydan; Ana Töpf; Ece Sonmezler; Hanns Lochmüller; Rita Horvath; Yavuz Oktay
Journal:  J Neuromuscul Dis       Date:  2019

2.  Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings.

Authors:  Pankaj B Agrawal; Mugdha Joshi; Nicholas S Marinakis; Klaus Schmitz-Abe; Pedro D S C Ciarlini; Jane C Sargent; Kyriacos Markianos; Umberto De Girolami; David A Chad; Alan H Beggs
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

3.  Novel mutations in MYBPC1 are associated with myogenic tremor and mild myopathy.

Authors:  Janis Stavusis; Baiba Lace; Jochen Schäfer; Janelle Geist; Inna Inashkina; Dita Kidere; Sander Pajusalu; Nathan T Wright; Annika Saak; Manja Weinhold; Dietrich Haubenberger; Sandra Jackson; Aikaterini Kontrogianni-Konstantopoulos; Carsten G Bönnemann
Journal:  Ann Neurol       Date:  2019-05-17       Impact factor: 10.422

4.  Muscular MRI-based algorithm to differentiate inherited myopathies presenting with spinal rigidity.

Authors:  Mickael Tordjman; Ivana Dabaj; Pascal Laforet; Adrien Felter; Ana Ferreiro; Moustafa Biyoukar; Bruno Law-Ye; Edmar Zanoteli; Claudia Castiglioni; John Rendu; Christophe Beroud; Alexandre Chamouni; Pascale Richard; Dominique Mompoint; Susana Quijano-Roy; Robert-Yves Carlier
Journal:  Eur Radiol       Date:  2018-05-25       Impact factor: 5.315

Review 5.  Muscle MRI in pediatrics: clinical, pathological and genetic correlation.

Authors:  Claudia P Cejas; Maria M Serra; David F Gonzalez Galvez; Eliana A Cavassa; Ana L Taratuto; Gabriel A Vazquez; Mario E L Massaro; Angeles V Schteinschneider
Journal:  Pediatr Radiol       Date:  2017-01-19

6.  Congenital myopathies: Natural history of a large pediatric cohort.

Authors:  Irene Colombo; Mariacristina Scoto; Adnan Y Manzur; Stephanie A Robb; Lorenzo Maggi; Vasantha Gowda; Thomas Cullup; Michael Yau; Rahul Phadke; Caroline Sewry; Heinz Jungbluth; Francesco Muntoni
Journal:  Neurology       Date:  2014-11-26       Impact factor: 9.910

Review 7.  MR imaging of inherited myopathies: a review and proposal of imaging algorithms.

Authors:  Laís Uyeda Aivazoglou; Julio Brandão Guimarães; Thomas M Link; Maria Alice Freitas Costa; Fabiano Nassar Cardoso; Bruno de Mattos Lombardi Badia; Igor Braga Farias; Wladimir Bocca Vieira de Rezende Pinto; Paulo Victor Sgobbi de Souza; Acary Souza Bulle Oliveira; Alzira Alves de Siqueira Carvalho; André Yui Aihara; Artur da Rocha Corrêa Fernandes
Journal:  Eur Radiol       Date:  2021-04-21       Impact factor: 5.315

8.  Congenital fiber-type disproportion in an ambulatory rehabilitation setting : A case report.

Authors:  Stefano Palma; Mohammad Keilani; Tim Hasenoehrl; Clemens Ambrozy; Sara Dana; Thomas Sycha; Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2017-07-25

9.  A recessive mutation in beta-IV-spectrin (SPTBN4) associates with congenital myopathy, neuropathy, and central deafness.

Authors:  Ellen Knierim; Esther Gill; Franziska Seifert; Susanne Morales-Gonzalez; Sathya D Unudurthi; Thomas J Hund; Werner Stenzel; Markus Schuelke
Journal:  Hum Genet       Date:  2017-05-24       Impact factor: 4.132

10.  ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy.

Authors:  Rocío N Villar-Quiles; Fabio Catervi; Eva Cabet; Raul Juntas-Morales; Casie A Genetti; Teresa Gidaro; Asuman Koparir; Adnan Yüksel; Sandra Coppens; Nicolas Deconinck; Emma Pierce-Hoffman; Xavière Lornage; Julien Durigneux; Jocelyn Laporte; John Rendu; Norma B Romero; Alan H Beggs; Laurent Servais; Mireille Cossée; Montse Olivé; Johann Böhm; Isabelle Duband-Goulet; Ana Ferreiro
Journal:  Ann Neurol       Date:  2019-12-27       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.